Skip to main content
slideshow image

Purpose-Built GMP Facility in Bedford, MA

Available Q1 2023

Property overview

Ready to move from pipeline into full production? Bring your innovation to market at 172 Middlesex, a state-of-the-art GMP facility with 140,000 square feet in Bedford, Massachusetts.

Currently under construction, 172 Middlesex is well suited to scaling biotechnology and pharmaceutical companies. Designed as a modern, Life Sciences production facility, this site is conveniently located to support both talent attraction and distribution of finished product.

Bedford is home to an evolving biotech and manufacturing cluster, proximal to major distribution routes, and offers easy access to Boston and Cambridge. Take advantage of the many nearby amenity options—food retail, dining, shopping, childcare, as well as ample green space including several conservation areas.

Scalability, flexibility, and expertise
172 Middlesex is designed to fully accommodate the complexity of biomanufacturing facility technologies and processes.

140,000 square feet of space divided between a 100,000-square-foot first floor and 40,000-square-foot second floor, providing for delineation of key processes

36-foot high ceilings plus typical column bay spacing of 40 feet by 40 feet in the high bay area and approximately 30 feet by 40 feet elsewhere for maximum safety and efficiency in equipment and process layout

Two freight elevators with 3500lb and 5000lb weight capacities for materials transport

Four tailgate-height loading docks for efficient materials flow and flexibility to dedicate specific docks for specific processes and quality procedures aligned with GMP facility design

Utility systems providing up to 6,000 amps for a reliable power supply and spaces to support critical mechanical equipment needed for Life Sciences production, including a reinforced roof to accommodate generators and other systems

With its convenient location, 172 Middlesex is ready for your growth.

icon

Strategically located in the heart of the dynamic Bedford Life Sciences and technology cluster.

icon

Within a 10 mile radius, this location stands shoulder to shoulder with some of the nation's top-notch lab clusters in Lexington, Burlington, and Waltham.

Building Specs

Features

  • Total: 140,000 SF on 14 acres
    First Floor: 100,000 SF
    Second Floor: 40,000 SF

  • 300 parking spaces 
    (2.20/1,000 SF)

Floor Plans

Tenant SpecLeasing Deck

The Team

Oxford Properties Group

Developing in partnership with
The Gutierrez Company.

Mary Lupoli
mlupoli@oxfordproperties.com

CBRE

John Lashar
Vice Chairman
617.439.7887
john.lashar@cbre.com

Eric Smith
Executive Vice President
617.933.0176
eric.smith@cbre.com

Brian McKenzie
Executive Vice President
617.439.7813
brian.mckenzie@cbre.com

Perry Beal
Senior Vice President
617.933.0043
perry.beal@cbre.com

Kendall Rowley
Senior Associate
617.936.2297
kendall.rowley@cbre.com

Oxford Properties Group

As a leading global real estate business, Oxford currently oversees more than 3 million SF of Life Sciences space across a mix of managed properties and development projects. We provide the platforms, amenities and services Life Sciences companies need to grow and prosper. Our fully integrated, global portfolio supports business at all stages of work in the sector, from early research and development through to production and manufacturing. In the US, Oxford’s Life Sciences portfolio is supported by expert on-the-ground presence in Boston, San Francisco, Washington DC and New York. Oxford is owned by OMERS, the defined benefit pension plan for over 500,000 of Ontario’s municipal employees with $90B in net assets.